If I remember correctly, those options were valued
Post# of 72440
To me the single biggest piece of evidence that things are going well with clinical trials is the willingness of the Ashcroft firm to take options priced at more than 50 cents above current share price, in lieu of cash.
Yoo hoo world, anyone listening? The guys who know everything there is to know about CTIX won't make a really good profit until CTIX is about a buck up from here.....